id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1657-0008,FDA,FDA-2013-E-1657,Letter from U.S. Patent and Trademark Office to Goodwin Proctor LLP,Other,Letter(s),2016-02-10T05:00:00Z,2016,2,2016-02-10T05:00:00Z,,2016-02-10T15:11:32Z,,0,0,0900006481e5cb07